Evidence map›Paper›PMID 39987159›Full record

ArticleScientific reports2025

Melanin from the fungus Gliocephalotrichum simplex protects seeds from the effects of exposure to gamma radiation.

Swaraj Kunal, Sushrut Bhanushali, Seshagiri Raghukumar, Ekaterina Dadachova

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Swaraj KunalAvisa Myko, Inc, c/o. IndieBio, 2565, 3rd Street, San Francisco, CA, 94107, USA.
Sushrut BhanushaliAvisa Myko, Inc, c/o. IndieBio, 2565, 3rd Street, San Francisco, CA, 94107, USA.
Seshagiri RaghukumarAvisa Myko, Inc, c/o. IndieBio, 2565, 3rd Street, San Francisco, CA, 94107, USA. raghu@avisamyko.com.
Ekaterina DadachovaCollege of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, S7N 5E5, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Protection of seeds from ionizing radiation is an important future need in space travel. We examined the usefulness of eumelanin from the fungus Gliocephalotrichum MTCC 5489 for this purpose. Seeds of Oryza sativa, Brassica nigra, Vigna radiata and V. aconitifolia were enclosed in Petri dishes coated with paint containing various concentrations of nanomelanin and exposed to doses of 0.1 to 2.0 kGy Cs-137 or 0.1 to 0.5 kGy Co-60 radiation. While Cs-137 radiation severely affected the rate of germination (germination index, GI) and germination percentage of Oryza sativa, whereas other seeds were less affected, Co-60 markedly diminished the GI of all the seeds. Increasing concentrations of melanin coating afforded significant protection to the GI of O. sativa seeds exposed to Cs-137 and to all seeds exposed to Co-60 radiation. The germination percentage of seeds was dose- and radiation dependent, with no effect observed for all doses of Cs-137 or 0.1 kGy Co-60 radiation, whereas 0.5 kGy Co-60 radiation killed 50 to 60% of the unprotected seeds. Melanin paint offered nearly 100% survival. This study demonstrated that melanin-containing materials can provide effective shielding from gamma radiation for diverse types of seeds that are important for human consumption, which has implications for space agriculture and agriculture in extreme environments.

Indexed as

Gamma RaysHypocrealesMelaninsRadiation-Protective AgentsSeedsCobalt RadioisotopesGerminationOryzaCobalt-60Cobalt RadioisotopesMelaninsRadiation-Protective AgentsGamma radiationGliocephalotrichum fungusMelaninRadioprotectionSpace agriculture

Identifiers

PMID39987159
PMCPMC11846945

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.